US Patent Issued to Regeneron Pharmaceuticals on Sept. 1 for "Radiolabeled anti-LAG3 antibodies for immuno-PET imaging" (New York, Utah Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,914, issued on Sept. 1, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Radiolabeled anti-LAG3 antibodies for immuno-PET imaging" was invented by Marcus Kelly (New York), Dangshe Ma (Pleasantville, N.Y.), William Olson (Yorktown Heights, N.Y.), Gavin Thurston (Millerton, N.Y.) and Richard Tavare (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Radiolabeled anti-LAG3 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of LAG3 proteins in a patient or sample."

The patent was filed on Oct. 25, 2022, under Application No. 18/049,609.

*For further informatio...